Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiyun Deng
Observed name:
Deng, Qiyun
Institutions:
Institut du cancer Rosalind & Morris Goodman,
McGill University
Observed institutions:
Institut du cancer Rosalind & Morris Goodman,
McGill University
ORCID:
0000-0002-6900-2587
Observed ORCID:
0000-0002-6900-2587
OpenAlex ID:
A5013432111
Works
9
Awards
1
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation
2022
·
Zhang Xu
, Jung-Hyun Choi
, et al.
·
Proceedings of the National Academy of Sciences
·
103
The mTOR chromatin-bound interactome in prostate cancer
2022
·
Catherine R. Dufour
, Charlotte Scholtes
, et al.
·
Cell Reports
·
30
PDF
Impact of eIF2α phosphorylation on the translational landscape of mouse embryonic stem cells
2023
·
Mehdi Amiri
, Stephen J. Kiniry
, et al.
·
Cell Reports
·
22
A therapeutic vulnerability linking MNK1/2 inhibition and G1/S cyclin-dependent kinase blockade in triple-negative breast cancer
2026
·
Qiyun Deng
, Mehdi Amiri
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
eIF2B Selectively Anchors and Activates Mutant KRAS
2025
·
Hyungdong Kim
, Shiqi Diao
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Targeting the translation initiation complex in therapy-resistant and metastatic melanoma
2024
·
Yongmei Feng
, Ximena Diaz-Olea
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract PR011: Inhibiting eIF4E phosphorylation sensitizes triple-negative breast cancer to CDK4/6 inhibition
2024
·
Qiyun Deng
, Mehdi Amiri
, et al.
·
Molecular Cancer Therapeutics
Abstract A014: Inhibiting eIF4E phosphorylation sensitizes triple-negative breast cancer to CDK4/6 inhibition
2024
·
Qiyun Deng
, Mehdi Amiri
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
9
Citation count:
155
H-index:
3
I10-index:
3
Year
Topic
Type